Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-12 Sale |
2025-03-14 5:20 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
15,521 | $53.3 | $827,233 | 103,901 (Direct) |
View |
2025-03-10 Sale |
2025-03-12 5:20 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
75,420 | $53.08 | $4,003,305 | 176,075 (Direct) |
View |
2025-02-19 Sale |
2025-02-21 5:20 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
2,947 | $50.11 | $147,678 | 103,901 (Direct) |
View |
2025-01-07 Sale |
2025-01-10 5:20 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
3,541 | $44.87 | $158,871 | 106,848 (Direct) |
View |
2024-12-02 Sale |
2024-12-04 5:20 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
95,908 | $52.37 | $5,022,334 | 255,721 (Direct) |
View |
2024-01-30 Sale |
2024-02-01 4:17 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
794 | $27.25 | $21,637 | 71,189 (Direct) |
View |
2024-01-08 Sale |
2024-01-10 4:04 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
3,395 | $28.85 | $97,960 | 71,983 (Direct) |
View |
2023-04-17 Sale |
2023-04-19 4:09 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
61,923 | $51.42 | $3,183,830 | 518,859 (Direct) |
View |
2023-01-31 Sale |
2023-02-02 4:18 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
812 | $45.63 | $37,050 | 75,378 (Direct) |
View |
2023-01-10 Sale |
2023-01-12 4:38 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
1,085 | $43.58 | $47,288 | 76,190 (Direct) |
View |
2023-01-09 Sale |
2023-01-11 6:14 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
835 | $41.66 | $34,783 | 77,275 (Direct) |
View |
2022-10-17 Sale |
2022-10-19 4:09 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
6,901 | $55 | $379,572 | 664,691 (Direct) |
View |
2022-09-20 Sale |
2022-09-22 4:38 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
1,176 | $55 | $64,680 | 547,658 (Direct) |
View |
2022-04-13 Sale |
2022-04-15 4:02 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
2,276 | $45.17 | $102,811 | 479,710 (Direct) |
View |
2022-04-05 Sale |
2022-04-07 4:03 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
5 | $45 | $225 | 481,986 (Direct) |
View |
2022-02-10 Sale |
2022-02-11 4:11 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
17,935 | $45.03 | $807,559 | 481,991 (Direct) |
View |
2022-02-01 Sale |
2022-02-03 4:57 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
779 | $40 | $31,162 | 61,110 (Direct) |
View |
2022-01-07 Sale |
2022-01-11 4:19 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
885 | $38.52 | $34,095 | 115,889 (Direct) |
View |
2021-09-02 Sale |
2021-09-03 4:06 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
3,363 | $45.01 | $151,375 | 433,381 (Direct) |
View |
2021-07-08 Sale |
2021-07-12 4:26 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
9,234 | $45.19 | $417,274 | 592,046 (Direct) |
View |
2021-02-01 Sale |
2021-02-02 6:23 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
778 | $56.96 | $44,312 | 48,374 (Direct) |
View |
2021-01-05 Sale |
2021-01-07 5:05 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
772 | $62.37 | $48,150 | 38,952 (Direct) |
View |
2020-07-07 Sale |
2020-07-09 4:08 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
30,625 | $55.12 | $1,688,037 | 378,061 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-12 Exercise |
2025-03-14 5:20 pm |
N/A N/A |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
15,521 | $33.02 | 103,901 (Direct) |
View |
2025-03-12 Exercise |
2025-03-14 5:20 pm |
N/A 2029-01-21 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
15,521 | $0 | 103,901 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 5:20 pm |
N/A N/A |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
64,171 | $33.02 | 176,075 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 5:20 pm |
N/A N/A |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
11,249 | $25.69 | 176,075 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 5:20 pm |
N/A 2029-01-21 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
75,420 | $0 | 176,075 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 5:20 pm |
N/A 2035-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
63,000 | $0 | 155,389 (Direct) |
View |
2024-12-03 Exercise |
2024-12-04 5:20 pm |
N/A N/A |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
10,308 | $33.02 | 255,721 (Direct) |
View |
2024-12-02 Exercise |
2024-12-04 5:20 pm |
N/A N/A |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
85,600 | $51 | 255,721 (Direct) |
View |
2024-12-02 Exercise |
2024-12-04 5:20 pm |
N/A 2025-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
95,908 | $0 | 255,721 (Direct) |
View |
2024-02-15 Option Award |
2024-02-16 4:10 pm |
N/A 2034-02-14 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
66,200 | $0 | 137,389 (Direct) |
View |
2023-04-17 Exercise |
2023-04-19 4:09 pm |
N/A 2026-01-03 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
61,923 | $30.86 | 518,859 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:56 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
53,250 | $0 | 114,360 (Direct) |
View |
2022-10-17 Exercise |
2022-10-19 4:09 pm |
N/A 2026-01-03 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
6,901 | $30.86 | 664,691 (Direct) |
View |
2022-09-20 Exercise |
2022-09-22 4:38 pm |
N/A 2026-01-03 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
1,176 | $30.86 | 547,658 (Direct) |
View |
2022-04-13 Exercise |
2022-04-15 4:02 pm |
N/A 2027-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
2,276 | $11.23 | 479,710 (Direct) |
View |
2022-04-05 Exercise |
2022-04-07 4:03 pm |
N/A 2027-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
5 | $11.23 | 481,986 (Direct) |
View |
2022-02-10 Exercise |
2022-02-11 4:11 pm |
N/A 2027-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
2,282 | $11.23 | 481,991 (Direct) |
View |
2022-02-10 Exercise |
2022-02-11 4:11 pm |
N/A 2028-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
15,653 | $18.01 | 481,991 (Direct) |
View |
2022-01-07 Option Award |
2022-01-11 4:19 pm |
N/A 2032-01-06 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
68,400 | $0 | 115,889 (Direct) |
View |
2021-09-02 Exercise |
2021-09-03 4:06 pm |
N/A 2028-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
3,363 | $18.01 | 433,381 (Direct) |
View |
2021-07-08 Exercise |
2021-07-12 4:26 pm |
N/A 2027-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
2,000 | $11.23 | 592,046 (Direct) |
View |
2021-07-08 Exercise |
2021-07-12 4:26 pm |
N/A 2028-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
7,234 | $18.01 | 592,046 (Direct) |
View |
2021-01-06 Option Award |
2021-01-08 5:17 pm |
N/A 2031-01-05 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
69,700 | $0 | 108,652 (Direct) |
View |
2020-07-07 Exercise |
2020-07-09 4:08 pm |
N/A 2027-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
13,125 | $11.23 | 378,061 (Direct) |
View |
2020-07-07 Exercise |
2020-07-09 4:08 pm |
N/A 2028-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
17,500 | $18.01 | 378,061 (Direct) |
View |